Role of microRNAs in intervertebral disc degeneration (Review)

Fengguang Yang1, Jizu Wang1, Zhixin Chen1

  • 1Department of Orthopedics, Gansu Provincial Hospital, Lanzhou, Gansu 730000, P.R. China.

Insights

MicroRNAs (miRNAs) are increasingly linked to intervertebral disc degeneration (IDD), a common cause of lower back pain. Understanding miRNA roles may lead to early diagnosis and new treatments for IDD.

Area of Science:

  • Biomedical Science
  • Molecular Biology
  • Regenerative Medicine

Background:

  • Intervertebral disc degeneration (IDD) is a growing cause of lower back pain, significantly impacting quality of life and incurring socioeconomic costs.
  • Current treatments for IDD are limited due to poorly understood underlying mechanisms.
  • MicroRNAs (miRNAs) are implicated in the pathogenesis of various diseases, including IDD.

Purpose of the Study:

  • To review recent advances in understanding the role of miRNAs in the mechanisms of intervertebral disc degeneration (IDD).
  • To explore how abnormal miRNA expression contributes to pathological processes in IDD.
  • To highlight the potential of miRNAs as diagnostic markers and therapeutic targets for IDD.

Main Methods:

  • Literature review focusing on studies investigating miRNA involvement in IDD pathogenesis.
  • Analysis of research on miRNA dysregulation in nucleus pulposus (NP) cells (NPCs) and extracellular matrix.
  • Examination of studies on miRNA influence on NPC proliferation, apoptosis, and inflammation.

Main Results:

  • Abnormal miRNA expression is associated with key pathological changes in IDD.
  • miRNAs regulate critical processes such as NPC proliferation, apoptosis, extracellular matrix remodeling, and inflammation.
  • Specific miRNAs are implicated in changes within the cartilaginous endplate, a hallmark of IDD.

Conclusions:

  • MicroRNAs play a significant role in the molecular mechanisms driving intervertebral disc degeneration (IDD).
  • Further research into miRNA functions is crucial for developing early diagnostic markers for IDD.
  • Targeting miRNAs presents a promising avenue for novel therapeutic strategies to delay or reverse IDD.